Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Aldosterone Regulates Pendrin and Epithelial Sodium Channel Activity through Intercalated Cell Mineralocorticoid Receptor-Dependent and -Independent Mechanisms over a Wide Range in Serum Potassium.

Pham TD, Verlander JW, Wang Y, Romero CA, Yue Q, Chen C, Thumova M, Eaton DC, Lazo-Fernandez Y, Wall SM.

J Am Soc Nephrol. 2020 Feb 13. pii: ASN.2019050551. doi: 10.1681/ASN.2019050551. [Epub ahead of print]

PMID:
32054691
2.

Nitric oxide reduces Cl⁻ absorption in the mouse cortical collecting duct through an ENaC-dependent mechanism.

Pech V, Thumova M, Dikalov SI, Hummler E, Rossier BC, Harrison DG, Wall SM.

Am J Physiol Renal Physiol. 2013 Jun 1;304(11):F1390-7. doi: 10.1152/ajprenal.00292.2012. Epub 2013 Mar 20.

3.

Pendrin protein abundance in the kidney is regulated by nitric oxide and cAMP.

Thumova M, Pech V, Froehlich O, Agazatian D, Wang X, Verlander JW, Kim YH, Wall SM.

Am J Physiol Renal Physiol. 2012 Sep 15;303(6):F812-20. doi: 10.1152/ajprenal.00577.2011. Epub 2012 Jul 18.

4.

ENaC inhibition stimulates Cl- secretion in the mouse cortical collecting duct through an NKCC1-dependent mechanism.

Pech V, Thumova M, Kim YH, Agazatian D, Hummler E, Rossier BC, Weinstein AM, Nanami M, Wall SM.

Am J Physiol Renal Physiol. 2012 Jul 1;303(1):F45-55. doi: 10.1152/ajprenal.00030.2012. Epub 2012 Apr 11.

5.

Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.

Rakusan D, Kujal P, Kramer HJ, Husková Z, Vanourková Z, Vernerová Z, Mrázová I, Thumová M, Cervenka L, Vanecková I.

Am J Physiol Renal Physiol. 2010 Oct;299(4):F758-66. doi: 10.1152/ajprenal.00259.2010. Epub 2010 Jul 28.

6.

Inappropriately high circulating and intrarenal angiotensin II levels during dietary salt loading exacerbate hypertension in Cyp1a1-Ren-2 transgenic rats.

Husková Z, Vanourková Z, Erbanová M, Thumová M, Opocenský M, Mullins JJ, Kramer HJ, Bürgelová M, Cervenka L.

J Hypertens. 2010 Mar;28(3):495-509. doi: 10.1097/HJH.0b013e3283345d69.

PMID:
19927008
7.

Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.

Bürgelová M, Vanourková Z, Thumová M, Dvorák P, Opocenský M, Kramer HJ, Zelízko M, Malý J, Bader M, Cervenka L.

J Hypertens. 2009 Oct;27(10):1988-2000. doi: 10.1097/HJH.0b013e32832f0d06.

PMID:
19593210
8.

Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats.

Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Malý J, Kramer HJ, Dvorák P, Cervenka L.

Vascul Pharmacol. 2009 Aug-Sep;51(2-3):175-81. doi: 10.1016/j.vph.2009.06.001. Epub 2009 Jun 16.

PMID:
19539780
9.

Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.

Erbanová M, Thumová M, Husková Z, Vanecková I, Vanourková Z, Mullins JJ, Kramer HJ, Bürgelová M, Rakusan D, Cervenka L.

J Hypertens. 2009 Mar;27(3):575-86.

PMID:
19330918
10.

Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice.

Cervenka L, Vanecková I, Husková Z, Vanourková Z, Erbanová M, Thumová M, Skaroupková P, Opocenský M, Malý J, Chábová VC, Tesar V, Bürgelová M, Viklický O, Teplan V, Zelízko M, Kramer HJ, Navar LG.

J Hypertens. 2008 Jul;26(7):1379-89. doi: 10.1097/HJH.0b013e3282fe6eaa.

11.

Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats.

Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Cervenka L, Majid DS.

J Hypertens. 2007 Nov;25(11):2257-65.

PMID:
17921820
12.

The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats.

Certíková Chábová V, Kramer HJ, Vanecková I, Thumová M, Skaroupková P, Tesar V, Falck JR, Imig JD, Cervenka L.

Kidney Blood Press Res. 2007;30(5):335-46. Epub 2007 Aug 30.

13.

Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.

Chábová VC, Kramer HJ, Vanecková I, Vernerová Z, Eis V, Tesar V, Skaroupková P, Thumová M, Schejbalová S, Husková Z, Vanourková Z, Kolský A, Imig JD, Cervenka L.

Vascul Pharmacol. 2007 Aug-Sep;47(2-3):145-59. Epub 2007 Jun 2.

PMID:
17604232
14.

Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.

Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L.

Kidney Blood Press Res. 2007;30(1):45-55. Epub 2007 Jan 25.

15.

AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension.

Vanourková Z, Kramer HJ, Husková Z, Vanecková I, Opocenský M, Chábová VC, Tesar V, Skaroupková P, Thumová M, Dohnalová M, Mullins JJ, Cervenka L.

J Hypertens. 2006 Dec;24(12):2465-72.

PMID:
17082731
16.

Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.

Husková Z, Kramer HJ, Thumová M, Vanourková Z, Bürgelová M, Teplan V, Malý J, Cervenka L.

Kidney Blood Press Res. 2006;29(2):74-83. Epub 2006 Apr 27.

17.

Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal Ang II activity.

Bürgelová M, Kramer HJ, Teplan V, Thumová M, Cervenka L.

Kidney Int. 2005 Apr;67(4):1453-61.

Supplemental Content

Loading ...
Support Center